Use of Nandrolone Decanoate as an Adjuvant for Erythropoietin Dose Reduction in Treating Anemia in Patients on Hemodialysis

Publisher： Karger

E-ISSN： 1660-2110|99|4|c102-c106

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.99, Iss.4, 2005-02, pp. : c102-c106

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nandrolone Decanoate as Anabolic Therapy in Chronic Kidney Disease: A Randomized Phase II Dose-Finding Study

By  

Nephron Clin Pract, Vol. 106, Iss. 3, 2007-05 ,pp. : c125-c135

Karger

Access to resources Recommend Favorite

Inflammation and Resistance to Erythropoietin in Hemodialysis Patients

By  

Acta Haematologica, Vol. 108, Iss. 3, 2002-09 ,pp. : 168-170

Karger

Access to resources Recommend Favorite

Erythropoietin May Improve Anemia in Patients with Autoimmune Hemolytic Anemia Associated with Reticulocytopenia

By  

Transfusion Medicine and Hemotherapy, Vol. 39, Iss. 3, 2012-05 ,pp. : 221-223

Karger

Access to resources Recommend Favorite

Circulating Levels of Thrombopoietin and Erythropoietin in Hemodialysis Patients

By  

Acta Haematologica, Vol. 109, Iss. 4, 2003-07 ,pp. : 209-211

Karger

Access to resources Recommend Favorite

Biocompatibility and Permeability of Dialyzer Membranes Do Not Affect Anemia, Erythropoietin Dosage or Mortality in Japanese Patients on Chronic Non-Reuse Hemodialysis: A Prospective Cohort Study from the J-DOPPS II Study

By  

Nephron Clin Pract, Vol. 109, Iss. 2, 2008-07 ,pp. : c100-c108

Karger

Access to resources Recommend Favorite